Nathan Cherrington

UA researchers link liver disease, drug metabolism

Researchers at the University of Arizona College of Pharmacy have discovered that nonalcoholic steatohepatitis (NASH), an increasingly common but often undiagnosed liver disease, could have significant medical implications for people with type 2 diabetes. John Clarke, PhD, research associate, and Nathan Cherrington, PhD, professor, both of the college’s Department of Pharmacology and Toxicology, recently published a study in the journal Diabetes showing that a mouse model of obesity, diabetes and NASH retaine

Pages

Subscribe to RSS - Nathan Cherrington